A 76-year-old woman (body mass index 19.81 kg/m 2 ) was admitted to the Medical University of Warsaw for transvenous extraction of dislocated left ventricular (LV) leads and lead reimplantation. The patient had a history of hypertension, persistent atrial fibrillation, moderate mitral and tricuspid regurgitation, and chronic kidney disease. In addition, she previously suffered from a diffuse large B-cell lymphoma, hepatitis B, and right internal jugular vein thrombosis after central intravenous catheter placement for chemotherapy, and underwent splenectomy and hysterectomy in the past. Four years before admission she had an implantable cardioverter-defibrillator (ICD) implanted in the primary prevention of sudden cardiac death due to non-ischaemic cardiomyopathy, probably secondary to seven cycles of chemotherapy administered previously for diffuse large B-cell lymphoma. Subsequently, the ICD was upgraded to a resynchronisation therapy device. During follow-up LV lead dislocation was diagnosed. Unsuccessful attempts to extract the lead using simple traction and Byrd dilator sheaths were made. Due to the failure of the procedure, another LV lead was implanted. The history of previous cardiac implantable electronic device (CIED)-related procedures is presented in Figure 1A -E. During the index hospitalisation the final attempt to extract the dysfunctional leads was made. The newer LV lead was extracted using Byrd dilator sheaths. During the extraction of the older LV lead using the same technique, the lead was fractured. Then, the fragmented part of the lead was extracted through femoral access using a lasso catheter, and only the lead tip was left. Finally, two new leads (an atrial one and an LV one) were implanted successfully through the left subclavian vein (Suppl. Fig. 1F 
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During one-year follow-up, she was completely asymptomatic, and a high percentage of biventricular pacing was confirmed. In this report, we describe a rare, but potentially severe complication of numerous CIED-related procedures. Multiple procedures performed on venous vasculature, causing a possible intimal injury or vein stenosis provoked by indwelling leads, together with the patient's positive history of thrombosis seems to be the most reasonable explanation for the observed complication. With a rapidly growing population of CIED patients and increasing complexity of the procedures, SVC syndrome might be encountered more frequently in clinical practice. 
